Panbela Therapeutics PBLA reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:10 PM.

Here's what investors need to know about the announcement.

Earnings

Panbela Therapeutics missed estimated earnings by -171.0%, reporting an EPS of $-65.9 versus an estimate of $-24.34.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.36 which was followed by a 3.0% increase in the share price the next day.

To track all earnings releases for Panbela Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.